Schedule 13G ownership disclosure

Tonix Pharmaceuticals Holding Corp.

Security class unavailable · CUSIP: 890260508

Event date: 2018-12-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
243,189
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-073019
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
Dec 14, 2018
Reporting period
Dec 07, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub